Moderna had earlier posted a loss of $2.52 per share a year earlier, while analysts expected a loss of $3.96 per share.

The FDA will now consider Moderna's mRNA flu vaccine application after a dispute over clinical trial design. Moderna agreed to seek full ap...

The US Food and Drug Administration will now review Moderna's influenza vaccine. This comes after an initial refusal due to trial design is...

US Health Secretary Robert F. Kennedy Jr. stopped 22 vaccine projects. These projects used mRNA technology. The vaccines aimed to fight COV...

Emcure Pharmaceuticals and its subsidiary Gennova have resolved all legal disputes with US-based HDT Bio Corp. The parties have entered int...

The pact links two big players in the vaccine world that both missed out on the rush to develop and commercialize Covid shots quickly durin...

China, whose home-grown vaccines are seen as less effective than the Moderna and Pfizer-BioNTech mRNA shots, has been racing to develop vac...

Worried about the rise of new variants and impact on China’s economy, the US has repeatedly offered mRNA vaccines and other assistance to P...

Research has estimated that 19.8 million lives were saved by the vaccines in 2021.

Moderna alleges Pfizer/BioNTech, without permission, copied mRNA technology that Moderna had patented between 2010 and 2016, well before CO...

In the company's nearly 30,000 patient trial, conducted between December 2020 and September 2021, there were four cases of myocarditis, a t...

After the success of the covid vaccine, BioNTech is planning to return €2bn to shareholders. BioNTech will continue the clinical trial to b...

At a press briefing in Geneva on Wednesday, WHO Director-General Tedros Adhanom Ghebreyesus said the new hub will be in South Korea and wil...

Depending on wealthy nations to donate billions of doses is not working, public health experts say. The solution, many now believe, is for ...

While almost 1 billion people have been fully vaccinated in China, the country is still lacking an mRNA shot, with most of the population i...

On Friday, senior executives from companies such as Moderna, GSK and Bharat Biotech addressed various issues on Covid vaccines, including e...

"The idea that we have a 94.5 percent effective vaccine is stunningly impressive. It is really a spectacular result that I don't think anyb...